Professor Jochen Prehn’s research was a focus on the Sunday Times issue 19-2-17 where he talks about how a molecular test developed at the Royal College of Surgeons in Ireland (RCSI) can predict how bowel cancer will respond to chemotherapy, ensuring that patients for whom the procedure is potentially counterproductive do not need to get the treatment.
BowelScreen, a public screening programme, can help to diagnose bowel cancers earlier than before, according to Jochen Prehn, professor of physiology and medical physics at the RCSI, who led the research team.
The test was developed when RCSI gained access to cancer tissue from 400 patients who were part of two large studies in Ireland, Europe and America of people with bowel cancer.
